With Momentum

Chronomics

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

Tech-bio company, providing access to a ‘bio-infrastructure’ to simplify and speed-up the use of biomarkers to improve everyday decisions.

HQ Location

London (United Kingdom)

Founded

2017

Employees

11 - 50

Total funding raised

$1.43M

Last Funding Event

Seed, $1.43M, January 8, 2019

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M

Chronomics is a tech-bio company on a mission to make biology accessible and actionable to everyone. The world is at the dawn of a ‘bio-revolution’ - with science set to transform our lives in the coming decades. And yet today, accessing biological information - and making it actionable - is complex, costly and cumbersome. The revolution needs an engine - and we are building it. We design and deploy ‘bio-infrastructure’ across more than a dozen verticals to simplify, speed-up and scale the use of biomarkers to improve everyday decisions. From tele-health to travel; sleep to skincare; multivitamins to managing menopause - and many others - we partner with the world’s largest and most impactful organizations, using science to transform how they diagnose, personalize and evaluate their offerings. Co-located between the US and Europe, we’re a team that spans science, technology, supply chain, operations, commercial - and we’re growing. Rapidly.